.png){kind=icon}
.png){kind=icon}
Return
Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western Kenya
.png){kind=icon}
OA
AI
D
J
L
S
T
J
G
S
DOI：10.1093/ofid/ofag416.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
In trials, three-month weekly rifapentine and isoniazid (3HP) showed higher adherence and completion than the six-month daily isoniazid (6H) regimen for TB preventive treatment (TPT). However, programmatic outcome data remain limited.
Journal
IF:
3.8
Papers:
6.3K
Citations:
1.4W
Organization
Cited Papers